Avid Organics Plans Its First US Plant, Investing Up to USD 50 Million to Make Glycine and Glycolic Acid from 2028
Avid Organics, an India-headquartered specialty chemicals manufacturer, announced on 13 October 2026 that it plans to build its first manufacturing plant outside India, in the United States.
Key facts: • Investment: up to USD 50 million across its US operations through 2035, covering manufacturing infrastructure, process technology and local operating capabilities. • Products: initial output of glycine and glycolic acid in technical and cosmetic grades, with room to expand later. • Timing: operations targeted to begin in 2028. • Site: not yet final; the company says it is in active discussions. • The project will run through Avid Organics America Inc., the subsidiary that already distributes its products in the US.
CEO and Managing Director Dheeraj Jain called the US a strategic market and said local manufacturing would support long-term growth, using manufacturing and process know-how developed in India.
What it means for buyers and suppliers
Indian chemical makers are starting to build plants in their export markets to sit inside US supply chains. Glycine and glycolic acid go into food, pharma, agrochemical and personal-care products; Indian buyers should not see supply change, as the Indian plants continue, but US customers may shift some volumes to the new plant once it runs.
Source: Avid Organics press release (PR Newswire, 13 October 2026), as published by UNI India. Photo: glycine crystals under the microscope. A. T. Cameron, public domain, via Wikimedia Commons.